Natrixam (Indapamide, Amlodipine Besilate)

Indapamide and Amlodipine besilate, the active ingredients in Natrixam, are a thiazide‑like diuretic and calcium channel blocker presented as an oral tablet for oral use. It treats hypertension in adult patients. GNH USA supplies Natrixam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Natrixam is an antihypertensive combination that lowers elevated blood pressure through diuresis and arterial vasodilation. Hypertension: reduces systolic and diastolic blood pressure in patients with elevated blood pressure.

Common Side Effects: - Headache: mild to moderate intensity. - Peripheral edema: swelling of ankles or lower legs. - Dizziness or light‑headedness, especially after standing. - Flushing: warmth and redness of the skin. - Fatigue: feeling unusually tired. - Palpitations: awareness of heartbeat.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure. - Electrolyte imbalance: hyponatremia or hypokalemia. - Angioedema: swelling of face, lips, or throat. - Hepatic dysfunction: abnormal liver enzymes or jaundice. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Acute pancreatitis: severe abdominal pain with nausea.

Before initiating therapy, consider the following precautions: - Monitor blood pressure: ensure adequate control without excessive drop. - Assess renal function: adjust use in patients with impaired kidneys. - Check electrolytes: watch for sodium or potassium disturbances. - Use caution in severe hepatic impairment: dose may need adjustment. - Elderly patients: start at lower dose and monitor for orthostatic effects. - Store at ambient temperature: keep below 25°C in the original pack, protect from moisture.

When prescribing Natrixam, be aware of potential drug interactions. Major Interactions (Avoid): - Concomitant potent antihypertensives: risk of excessive hypotension. - NSAIDs: may blunt diuretic effect of indapamide. - Strong CYP3A4 inhibitors (e.g., clarithromycin): increase amlodipine levels. - Lithium: increased risk of lithium toxicity. - Potassium‑sparing diuretics: may cause hyperkalemia.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: additive blood‑pressure lowering effect. - Beta‑blockers: may mask tachycardia from hypotension. - Other diuretics: monitor electrolyte balance. - CYP3A4 inducers (e.g., rifampicin): may reduce amlodipine exposure. - Alcohol: can enhance dizziness and hypotensive response.